Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-586b7cd67f-gb8f7 Total loading time: 0 Render date: 2024-11-20T07:34:20.743Z Has data issue: false hasContentIssue false

Case 7: - Where did her period go?

Published online by Cambridge University Press:  03 April 2024

By
Mark Wiener  and
Cristiana Mihai
Edited by
Nevena V. Radonjić ,
Thomas L. Schwartz  and
Stephen M. Stahl
Nevena V. Radonjić
Affiliation:
State University of New York Upstate Medical University
Thomas L. Schwartz
Affiliation:
State University of New York Upstate Medical University
Stephen M. Stahl
Affiliation:
University of California, San Diego
Get access

Summary

Which antipsychotic medications are most commonly associated with causing hyperprolactinemia?

Keywords

schizophreniahyperprolactinemiacross-titrationamenorrheaaugmentationcombinationD2 partial agonistpaliperidone (invega Sustenna)haloperidol(Haldol)aripiprazole (Abilify)olanzapine (Zyprexa)quetiapine (Seroquel)risperidone (Risperdal)lurasidone (Latuda)
Type
Chapter
Information
Case Studies: Stahl's Essential Psychopharmacology , pp. 109 - 132
Publisher: Cambridge University Press
Print publication year: 2024

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Byerly, M, Suppes, T, Tran, QV, et al. Clinical implications of antipsychotic-induced hyperprolactinemia in patients with schizophrenia spectrum or bipolar spectrum disorders: recent developments and current perspectives. J Clin Psychopharmacol 2007; 27:639–61CrossRefGoogle ScholarPubMed
Holt, RI, Peveler, RC. Antipsychotics and hyperprolactinaemia: mechanisms, consequences and management. Clin Endocrinol (Oxf) 2011; 74:141–7CrossRefGoogle ScholarPubMed
Johnsen, E, Kroken, RA, Abaza, M, et al. Antipsychotic-induced hyperprolactinemia: a cross-sectional survey. J Clin Psychopharmacol 2008; 28:686–90CrossRefGoogle ScholarPubMed
Keck, PE, Jr., McElroy, SL. Aripiprazole: a partial dopamine D2 receptor agonist antipsychotic. Expert Opin Investig Drugs 2003; 12:655–62CrossRefGoogle ScholarPubMed
Melkersson, K. Differences in prolactin elevation and related symptoms of atypical antipsychotics in schizophrenic patients. J Clin Psychiatry 2005; 66:761–7CrossRefGoogle ScholarPubMed
Melmed, S, Casanueva, FF, Hoffman, AR, et al. Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011; 96:273–88CrossRefGoogle ScholarPubMed
Meng, M, Li, W, Zhang, S, et al. Using aripiprazole to reduce antipsychotic-induced hyperprolactinemia: meta-analysis of currently available randomized controlled trials. Shanghai Arch Psychiatry 2015; 27:4–17Google ScholarPubMed
Meyer, JM, Stahl, SM. The Clinical Use of Antipsychotic Plasma Levels. Cambridge: Cambridge University Press, 2021CrossRefGoogle Scholar
Miyamoto, BE, Galecki, M, Francois, D. Guidelines for antipsychotic-induced hyperprolactinemia. Psychiatr Ann 2015; 45:266–72CrossRefGoogle Scholar
Petty, RG. Prolactin and antipsychotic medications: mechanism of action. Schizophr Res 1999; 35 Suppl.:S67–73CrossRefGoogle ScholarPubMed
Stahl, SM. Stahl’s Essential Psychopharmacology: Neuroscientific Basis and Practical Applications, 5. Cambridge: Cambridge University Press, 2021CrossRefGoogle Scholar
Turrone, P, Kapur, S, Seeman, MV, et al. Elevation of prolactin levels by atypical antipsychotics. Am J Psychiatry 2002; 159:133–5CrossRefGoogle ScholarPubMed
Volavka, J, Czobor, P, Cooper, TB, et al. Prolactin levels in schizophrenia and schizoaffective disorder patients treated with clozapine, olanzapine, risperidone, or haloperidol. J Clin Psychiatry 2004; 65:57–61CrossRefGoogle ScholarPubMed
Wang, ZM, Xiang, YT, An, FR, et al. Frequency of hyperprolactinemia and its associations with demographic and clinical characteristics and antipsychotic medications in psychiatric inpatients in China. Perspect Psychiatr Care 2014; 50:257–63CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×